PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|180|5|705-714

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.5, 2018-03, pp. : 705-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Distribution of CTLA-4 Polymorphisms in Allergic Asthma

By  

International Archives of Allergy and Immunology, Vol. 141, Iss. 3, 2006-10 ,pp. : 223-229

Karger

Access to resources Recommend Favorite

Usage of Eltrombopag for Chronic Immune Thrombocytopenia as a Pretreatment for Splenectomy

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-10 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

The interferon receptor‐1 promoter polymorphisms affect the outcome of Caucasians with HBeAg‐negative chronic HBV infection

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2506-2513

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 408-415

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 304-307

John Wiley & Sons Inc

Access to resources Recommend Favorite